MediPharm Labs Corp. MEDIF
0.05 USD 0.00 (+0.00%)
Regular-session close
0.0449 Day range 0.0485
0.04 52-week range 0.076
- YTD
- -7.84%
- 1 year
- -4.08%
News
seekingalpha.com MediPharm Labs Corp. (LABS:CA) Q3 2026 Earnings Call Transcript MediPharm Labs Corp. (LABS:CA) Q3 2026 Earnings Call Transcript
globenewswire.com MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth Net Income was positive for the second consecutive quarter, and Adjusted EBITDA1 positive for its third consecutive quarter. Net Revenue of $11.8M increased 18% versus Q2 2026, with German revenue…
globenewswire.com MediPharm Labs Expands Brazilian Business with Commercial Launch of ANVISA-Authorized Cannabis Extract Oil TORONTO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), is pleased to announce the commercial launch of…
globenewswire.com MediPharm Labs Sets Date to Report Third Quarter 2026 Financial Results TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in…
globenewswire.com MediPharm Labs Achieves Critical European Regulatory Milestone Supporting Commercialization of Proprietary Metered-Dose Cannabis Inhaler Platform TORONTO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in…
globenewswire.com MediPharm Labs Appoints Greg Hunter as Chief Executive Officer and Director TORONTO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specializing in…
globenewswire.com MediPharm Labs Expands Its International Medical Cannabis Footprint with First CBD Metered-Dose Inhaler Shipment to Panama TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in…
seekingalpha.com MediPharm Labs Corp. (LABS:CA) Q2 2026 Earnings Call Transcript MediPharm Labs Corp. (LABS:CA) Q2 2026 Earnings Call Transcript
globenewswire.com MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA Q2 2026 Adjusted EBITDA1 of $0.9M, the Company's strongest quarterly performance since 20192 Positive net income in Q2 2026, compared with a net loss of $3.8M in Q2 2025 OPEX decreased 44% in Q2 2026…
globenewswire.com MediPharm Labs Sets Date to Report Second Quarter 2026 Financial Results TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in…
globenewswire.com MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer's Disease and Dementia TORONTO, July 14, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specializing in…
globenewswire.com MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in…
globenewswire.com MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting Annual and Special Meeting to be held virtually on Wednesday, June 17, 2026 at 11:00 a.m. (Eastern Time).
seekingalpha.com MediPharm Labs Corp. (LABS:CA) Q1 2026 Earnings Call Transcript MediPharm Labs Corp. (LABS:CA) Q1 2026 Earnings Call Transcript
globenewswire.com MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA Q1 2026 Positive Adjusted EBITDA(1) Net Revenue of $9M with strong gross margins of 37% OPEX decreased 28% in Q1 2026 versus Q4 2025 Company is virtually debt free, with a Q1 ending cash balance of…
globenewswire.com MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in…
globenewswire.com MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration's final order rescheduling FDA-approved cannabis drug products and state-licensed medical cannabis from Schedule…
seekingalpha.com MediPharm Labs Corp. (LABS:CA) Q4 2025 Earnings Call Transcript MediPharm Labs Corp. (LABS:CA) Q4 2025 Earnings Call Transcript
benzinga.com This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.
benzinga.com Cannabis Stock Gainers And Losers From August 16, 2023 GAINERS: Red White & Bloom Brands (OTC: RWBYF) shares closed up 300.00% at $0.04
benzinga.com Earnings Scheduled For August 13, 2020 Companies Reporting Before The Bell • Tapestry Inc. (NYSE:TPR) is estimated to report quarterly loss at $0.57 per share on revenue of $662.44 million.
benzinga.com Stocks That Hit 52-Week Highs On Tuesday 
benzinga.com Stocks That Hit 52-Week Lows On Friday 
benzinga.com Stocks That Hit 52-Week Lows On Thursday